Llwytho...
Advances in the assessment of minimal residual disease in mantle cell lymphoma
The clinical impact of minimal residual disease detection at early time points or during follow-ups has been shown to accurately predict relapses among patients with lymphomas, mainly in follicular and diffuse large B cell lymphoma. The field of minimal residual disease testing in mantle cell lympho...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Hematol Oncol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7513535/ https://ncbi.nlm.nih.gov/pubmed/32972438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-00961-8 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|